BioNTech SE ADR rises Friday, outperforms market
The BioNTech SE ADR BNTX advanced 2.40% to $122.68 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.90% to 5,751.07 and the ...
U.S. Stocks May See Initial Strength Following Upbeat Jobs Data
After showing a lack of direction over the two previous sessions, stocks are likely to show a strong move to the upside in early trading on Friday. The major index futures ...
BioNTech's (NASDAQ:BNTX) investors will be pleased with their massive 749% return over the last five years
While the best companies are hard to find, but they can generate massive returns over long periods. To wit, the BioNTech SE ...
Summit stock jumps as FDA grants fast track tag for lung cancer therapy
Summit Therapeutics (SMMT) shares surge 25% on FDA Fast Track designation for cancer drug ivonescimab in advanced lung cancer treatment.
BioNTech (BNTX) Presents at Innovation Series: AI Day
Company Conference Call October 1, 2024 9:00 AM ETCompany ParticipantsKarim Beguir - Chief Executive Officer, InstaDeepUğur ...
American Resources Corporation to Participate in the Virtual Investor Lunch Break Series
Live video webcast with Mark Jensen, CEO of American Resources on Thursday, October 3rd at 12:00 PM ET FISHERS, IN / ACCESSWIRE / September 30, 2024 / American Resources Corporation's (NASDAQ:AREC) (" ...
BioNTech SE (BNTX) Gets a Buy from Deutsche Bank
In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Buy rating on BioNTech SE (BNTX – Research Report), with ...
Gorilla Technology Group Inc.: Gorilla Technology Takes Strong Stance Against Market Manipulation
Gorilla Technology Group Inc. (NASDAQ: GRRR) ("Gorilla" or the "Company"), today issued a firm statement regarding its uncompromising approach ...
LakeShore Biopharma Co., Ltd.: LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation
LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, ...
UBS Sticks to Its Hold Rating for BioNTech SE (BNTX)
UBS analyst Eliana Merle maintained a Hold rating on BioNTech SE (BNTX – Research Report) today and set a price target of $131.00. The ...
TD Cowen Reaffirms Their Hold Rating on BioNTech SE (BNTX)
In a report released today, Yaron Werber from TD Cowen maintained a Hold rating on BioNTech SE (BNTX – Research Report), with a price ...
Google DeepMind, BioNtech Unveil AI Lab Assistants To Revolutionize Scientific Research
Google DeepMind by Alphabet Inc. (NASDAQ:GOOGL) (NASDAQ:GOOG) and BioNTech (NASDAQ:BNTX) are collaborating to develop AI lab ...